|
|
|
CUSIP No. 91914N 301
|
|
Page 8 of 10
|
The percentages of Shares beneficially owned by the Reporting Persons is based upon 8,271,503 Shares
outstanding as of September 30, 2019 as disclosed to the Reporting Persons by the Issuer in the Series B Purchase Agreement.
|
b)
|
With respect to the number of Shares, each Reporting Person has the sole power to vote or to direct the vote,
the shared power to vote or to direct the vote, the sole power to dispose or to direct the disposition of, and shared power to dispose or to direct the disposition of, see Items 7, 8, 9 and 10, respectively, on the cover pages hereto.
|
|
c)
|
A list of transactions in the Shares that were effected by the Reporting Persons during the past 60 days is
attached as Exhibit A hereto and is incorporated herein by reference.
|
Item 6. Contracts, Arrangements,
Understandings or Relationships with Respect to Securities of the Issuer
Item 6 is hereby amended as follows:
Term Loan Amendment No. 2
On
September 30, 2019, the Term Loan was further amended in order to: (i) increase the interest paid thereunder to 13% per annum; (ii) extend the time required prior to the initial required cash interest payments to March 31, 2022
from June 30, 2019; and (iii) provide the lenders under the term loan with a non-voting board observer right.
Pursuant to the Series B Purchase Agreement, the Issuer and the Funds (along with WCAS Capital Partners IV, L.P.) agreed to exchange their pro
rata portion of an aggregate $25.0 million of the outstanding principal amount of the Issuers debt into an aggregate of 17,123,284 shares of the Issuers to-be designated Series B Convertible
Preferred Stock at a purchase price of $1.46 per share. The Issuer also agreed to amend the terms of the Series A Convertible Preferred Stock. The Funds exchanged an aggregate of $22.7 million of indebtedness for an aggregate of 15,575,586
shares of Series B Convertible Preferred Stock.
Registration Rights Agreement Amendment No. 1
Contemporaneously with the execution of the Series B Purchase Agreement, the Issuer, the Funds and WCAS Capital Partners IV, L.P. also entered
into Amendment No. 1 to that certain Registration Rights Agreement dated February 14, 2017 (the RRA Amendment) pursuant to which the Issuer agreed to extend the registration rights to the Shares issuable upon conversion of the
Series B Convertible Preferred Stock.
The descriptions of the above agreements do not purport to be complete descriptions and are
qualified in their entirety by reference to the full text of such agreements, which are filed as part of this Schedule 13D and incorporated by reference herein.
Item 7. Material to be Filed as Exhibits
Item 7 is
hereby amended as follows:
|
|
|
Exhibit A
|
|
Transactions in Shares that were effected by the Reporting Persons during the past sixty days
|
|
|
Exhibit K
|
|
Amendment No. 2 to Second Amended and Restated Term Loan Agreement, dated as of February 9, 2017, by and among the Issuer, Capital Royalty Partners II L.P., Parallel Investment Opportunities Partners II, L.P., Capital
Royalty Partners IIParallel Fund A L.P., Capital Royalty Partners II (Cayman) L.P., Capital Royalty Partners IIParallel Fund B (Cayman) L.P. and WCAS Capital Partners IV, LP (incorporated by reference to Exhibit
10.2 to the Issuers Current Report on Form 8-K filed on October 2, 2019)
|
|
|
Exhibit L
|
|
Series B Preferred Stock Purchase Agreement, dated as of September 30, 2019, by and among the Issuer, Capital Royalty Partners II L.P., Parallel Investment Opportunities Partners II, L.P., Capital Royalty Partners
IIParallel Fund A L.P., Capital Royalty Partners II (Cayman) L.P., Capital Royalty Partners IIParallel Fund B (Cayman) L.P. and WCAS Capital Partners IV, LP (incorporated by reference to Exhibit 10.1 to the
Issuers Current Report on Form 8-K filed on October 2, 2019)
|